Juan Andres - 08 Jun 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Technical Operations and Quality Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
08 Jun 2022
Net transactions value
-$1,294,921
Form type
4
Filing time
10 Jun 2022, 16:08:46 UTC
Previous filing
01 Jun 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $28,695 +1,371 +13% $20.93* 11,738 08 Jun 2022 Direct F1
transaction MRNA Common Stock Options Exercise $41,860 +2,000 +17% $20.93* 13,738 08 Jun 2022 Direct F1
transaction MRNA Common Stock Options Exercise $41,860 +2,000 +15% $20.93* 15,738 08 Jun 2022 Direct F1
transaction MRNA Common Stock Options Exercise $41,860 +2,000 +13% $20.93* 17,738 08 Jun 2022 Direct F1
transaction MRNA Common Stock Options Exercise $41,860 +2,000 +11% $20.93* 19,738 08 Jun 2022 Direct F1
transaction MRNA Common Stock Options Exercise $8,944 +629 +3.2% $14.22* 20,367 08 Jun 2022 Direct F1
transaction MRNA Common Stock Sale $1,500,000 -10,000 -49% $150.00 10,367 08 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -1,371 -0.54% $0.000000 253,025 08 Jun 2022 Common Stock 1,371 $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2,000 -0.79% $0.000000 251,025 08 Jun 2022 Common Stock 2,000 $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2,000 -0.8% $0.000000 249,025 08 Jun 2022 Common Stock 2,000 $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2,000 -0.8% $0.000000 247,025 08 Jun 2022 Common Stock 2,000 $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2,000 -0.81% $0.000000 245,025 08 Jun 2022 Common Stock 2,000 $20.93 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -629 -100% $0.000000* 0 08 Jun 2022 Common Stock 629 $14.22 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.
F2 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer